FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced that Isoflex^® active, the trade name for bixlozone, has received regulatory approval in the European Union (EU). This approval is a critical milestone in FMC’s commercialization process, paving the way for the introduction of formulated products across more than 55 million planted hectares of cereals, corn, oilseed rape and potato in the EU.

FMC Corporation (NYSE: FMC) announced today it will release its first quarter 2026 earnings on Wednesday, April 29, 2026, after the stock market close via PR Newswire and the company’s website https://investors.fmc.com.

FMC Corporation (NYSE: FMC) today announced that Pierre Brondeau, FMC chairman, chief executive officer and president, and Andrew Sandifer, FMC executive vice president and chief financial officer, will speak at the J.P. Morgan Industrials conference on March 18, 2026, at 10:05 a.m. Eastern Time.  A live webcast will be available at www.fmc.com/investors

FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced the election of Michael F. Barry to the company’s Board of Directors, effective February 27, 2026. He will serve on the Audit and Compensation and Human Capital committees.

FMC Corporation (NYSE: FMC) announced today that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on April 16, 2026, to shareholders of record as of the close of business on March 31, 2026.   

------

FMC Corporation (NYSE: FMC) today announced that Pierre Brondeau, FMC chairman, chief executive officer and president, and Andrew Sandifer, FMC executive vice president and chief financial officer, will speak at the Bank of America Global Agriculture and Materials conference on February 25, 2026, at 2:45 p.m. Eastern Time. A live webcast will be available at www.fmc.com/investors.

FMC Corporation (NYSE: FMC) announced that the Herbicide Resistance Action Committee (HRAC) has classified rimisoxafen as a dual mode of action herbicide, designated under HRAC Groups 12 and 32. This is the first dual mode of action classification in HRAC's history, a significant milestone for the global crop protection industry and validation of FMC’s innovative approach to combating herbicide-resistant weeds.

• The organization continues to focus on its 2026 operational priorities, including strengthening the balance sheet, improving the competitiveness of its core portfolio, managing its post-patent Rynaxypyr® active strategy and supporting growth of new active ingredients

https://investors.fmc.com/news/news-details/2026/FMC-Corporation-Announ…

https://investors.fmc.com/news/news-details/2025/FMC-Corporation-announ…